CALL US
+91 9891296838/9811747774

INREBIC ® (fedratinib) capsules, for oral use Initial U.S. Approval: 2019.
Can be imported and made available on "patient name basis" treatment in India.

Inrebic (fedratinib) is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.

INREBIC is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).
Source content : www.accessdata.fda.gov

INREBIC® (fedratinib) capsules suppliers for India and other countries. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of INREBIC® (fedratinib) capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the INREBIC® (fedratinib) capsules medicine cost price in India.

The order for INREBIC® (fedratinib) capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Fedratinib, sold under the brand name Inrebic, is an anti-cancer medication used to treat myeloproliferative diseases including myelofibrosis. It is used in the form of fedratinib hydrochloride capsules that are taken by mouth. It is a semi-selective inhibitor of Janus kinase 2 (JAK-2). It was approved by the FDA on 16 August 2019. In the United States, fedratinib is indicated for the treatment of adults with intermediate-2 or high-risk primary or secondary (following polycythemia vera or essential thrombocythemia) myelofibrosis. In the European Union, fedratinib is indicated for the treatment of disease-related splenomegaly or symptoms in adults with primary myelofibrosis, following polycythaemia vera or essential thrombocythaemia, who are Janus kinase (JAK) inhibitor naïve or have been treated with ruxolitinib.

INREBIC® (fedratinib) capsules, for oral use.
Initial U.S. Approval: 2019

Capsules: 100 mg. Please see the Full Prescribing Information, including Patient Information, for INREBIC.
INREBIC® (fedratinib) capsules
You must agree before submitting.

News / Update for INREBIC (fedratinib) .

For INREBIC (fedratinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

U.S. FDA Approves INREBIC® (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis For More Details

Fedratinib Appears Safe for Long-Term Treatment of Intermediate- to High-Risk Myelofibrosis. For More Details

Steps to access INREBIC (fedratinib).

Step 1. You send a request for your medicine online:- Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2. We verify your prescription and medical details:- Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3. We source your medicine:- Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4. We deliver your medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation under Named-Patient import

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

INREBIC (fedratinib) exporter and suppliers in India

Can I get anti-cancer medicines even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of -
INREBIC (fedratinib) in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
INREBIC (fedratinib) in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
INREBIC (fedratinib) in North America – Mexico.
INREBIC (fedratinib) in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
INREBIC (fedratinib) in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
INREBIC (fedratinib) in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
INREBIC (fedratinib) in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
INREBIC (fedratinib) in Australia and New Zealand.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur